Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis.
Carmen Peña-BautistaLourdes Álvarez-SánchezInés FerrerMarina López-NoguerolesAntonio José Cañada-MartínezCamille OgerJean-Marie GalanoThierry DurandMiguel BaqueroConsuelo Cháfer-PericásPublished in: Antioxidants (Basel, Switzerland) (2021)
Plasma isoprostanoids could be useful biomarkers in preclinical diagnosis for AD. However, these results would require a further validation with an external cohort.